170 related articles for article (PubMed ID: 24124148)
1. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression.
Sojitra P; Gandhi P; Fitting P; Kini AR; Alkan S; Velankar MM; Venkataraman G
Am J Clin Pathol; 2013 Nov; 140(5):686-92. PubMed ID: 24124148
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Xu Y; McKenna RW; Karandikar NJ; Pildain AJ; Kroft SH
Am J Clin Pathol; 2005 Nov; 124(5):799-806. PubMed ID: 16203279
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
Harrington AM; Schelling LA; Ordobazari A; Olteanu H; Hosking PR; Kroft SH
Am J Clin Pathol; 2016 Aug; 146(2):170-81. PubMed ID: 27413139
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
6. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Analysis of Monocytes and Granulocytes May Be Useful in the Distinction of Myeloid Neoplasms from Reactive Conditions: A Single Institution Experience and Literature Review.
Brown LE; Zhang D; Cui W
Ann Clin Lab Sci; 2020 May; 50(3):327-332. PubMed ID: 32581021
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.
Birrer A; Jusufi F; Bernimoulin M; Tichelli A; Gratwohl A; Nissen-Druey C; Dirnhofer S; Meyer-Monard S; Stern M
Eur J Haematol; 2008 Oct; 81(4):267-72. PubMed ID: 18616511
[TBL] [Abstract][Full Text] [Related]
9. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells.
Kojima H; Bai A; Mukai HY; Hori M; Komeno T; Hasegawa Y; Ninomiya H; Mori N; Nagasawa T
Leuk Lymphoma; 2000 May; 37(5-6):617-21. PubMed ID: 11042523
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of detecting monocytic cells and their aberrancy.
Dunphy CH
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):336-40. PubMed ID: 21293259
[TBL] [Abstract][Full Text] [Related]
11. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
Leuk Lymphoma; 2011 Jan; 52(1):92-100. PubMed ID: 21219126
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
13. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
Harrington A; Olteanu H; Kroft S
Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
[TBL] [Abstract][Full Text] [Related]
14. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
Gorczyca W
Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
[No Abstract] [Full Text] [Related]
16. Chronic lymphocytic leukemia coexisting with chronic myelomonocytic leukemia.
Ferrara F; Del Vecchio L; Antonolfi I; Mele G; Rametta V; Cimino R
Haematologica; 1992; 77(2):171-3. PubMed ID: 1398303
[TBL] [Abstract][Full Text] [Related]
17. The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia.
Qubaja M; Marmey B; Le Tourneau A; Haiat S; Cazals-Hatem D; Fabiani B; Diebold J; Marie JP; Audouin J; Geissmann F; Molina TJ
Virchows Arch; 2009 Apr; 454(4):411-9. PubMed ID: 19242719
[TBL] [Abstract][Full Text] [Related]
18. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
[TBL] [Abstract][Full Text] [Related]
19. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.
Rollins-Raval MA; Roth CG
Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485
[TBL] [Abstract][Full Text] [Related]
20. Relative contributions of enzyme cytochemistry and flow cytometric immunophenotyping to the evaluation of acute myeloid leukemias with a monocytic component and of flow cytometric immunophenotyping to the evaluation of absolute monocytoses.
Dunphy CH; Orton SO; Mantell J
Am J Clin Pathol; 2004 Dec; 122(6):865-74. PubMed ID: 15539379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
